Symptom resolution after operative management of complications from transvaginal mesh
- PMID: 24463673
- PMCID: PMC4055867
- DOI: 10.1097/AOG.0000000000000042
Symptom resolution after operative management of complications from transvaginal mesh
Abstract
Objective: Complications from transvaginal mesh placed for prolapse often require operative management. The aim of this study is to describe the outcomes of vaginal mesh removal.
Methods: A retrospective review of all patients having surgery by the urogynecology group in the department of obstetrics and gynecology at our institution for a complication of transvaginal mesh placed for prolapse was performed. Demographics, presenting symptoms, surgical procedures, and postoperative symptoms were abstracted. Comparative statistics were performed using the χ or Fisher's exact test with significance at P<.05.
Results: Between January 2008 and April 2012, 90 patients had surgery for complications related to vaginal mesh and 84 had follow-up data. The most common presenting signs and symptoms were: mesh exposure, 62% (n=56); pain, 64% (n=58); and dyspareunia, 48% (n=43). During operative management, mesh erosion was encountered unexpectedly in a second area of the vagina in 5% (n=4), in the bladder in 1% (n=1), and in the bowel in 2% (n=2). After vaginal mesh removal, 51% (n=43) had resolution of all presenting symptoms. Mesh exposure was treated successfully in 95% of patients, whereas pain was only successfully treated in 51% of patients.
Conclusion: Removal of vaginal mesh is helpful in relieving symptoms of presentation. Patients can be reassured that exposed mesh can almost always be successfully managed surgically, but pain and dyspareunia are only resolved completely in half of patients.
Level of evidence: III.
Conflict of interest statement
Financial Disclosure: Dr. Delancey is a consultant for American Medical Systems. The other authors did not report any potential conflicts of interest.
Figures
Similar articles
-
Reoperations for mesh-related complications after pelvic organ prolapse repair: 8-year experience at a tertiary referral center.Int Urogynecol J. 2017 Aug;28(8):1139-1151. doi: 10.1007/s00192-016-3256-5. Epub 2017 Feb 1. Int Urogynecol J. 2017. PMID: 28150032
-
Persistent pelvic pain following transvaginal mesh surgery: a cause for mesh removal.Eur J Obstet Gynecol Reprod Biol. 2012 Jun;162(2):224-8. doi: 10.1016/j.ejogrb.2012.03.002. Epub 2012 Mar 30. Eur J Obstet Gynecol Reprod Biol. 2012. PMID: 22464208
-
Pain Resolution and Recurrent Prolapse Rates Following Vaginal Mesh Removal.Urology. 2021 Apr;150:134-138. doi: 10.1016/j.urology.2020.06.057. Epub 2020 Jul 13. Urology. 2021. PMID: 32673676
-
[Current state of transvaginal meshes by resolution of pelvic organ prolapse].Ceska Gynekol. 2017 Winter;82(1):72-78. Ceska Gynekol. 2017. PMID: 28252314 Review. Czech.
-
Surgical management of pelvic organ prolapse in women.Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004014. doi: 10.1002/14651858.CD004014.pub5. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2016 Nov 30;11:CD004014. doi: 10.1002/14651858.CD004014.pub6 PMID: 23633316 Updated. Review.
Cited by
-
Transvaginal mesh or grafts or native tissue repair for vaginal prolapse.Cochrane Database Syst Rev. 2024 Mar 13;3(3):CD012079. doi: 10.1002/14651858.CD012079.pub2. Cochrane Database Syst Rev. 2024. PMID: 38477494 Review.
-
Dysregulated inflammatory response to urogynecologic meshes in women with diabetes and its implications.Am J Obstet Gynecol. 2024 Jul;231(1):115.e1-115.e11. doi: 10.1016/j.ajog.2024.02.282. Epub 2024 Feb 24. Am J Obstet Gynecol. 2024. PMID: 38408622
-
How is pain associated with pelvic mesh implants measured? Refinement of the construct and a scoping review of current assessment tools.BMC Womens Health. 2022 Sep 30;22(1):396. doi: 10.1186/s12905-022-01977-7. BMC Womens Health. 2022. PMID: 36180841 Free PMC article. Review.
-
Characterization of vaginal immune response to a polypropylene mesh: Diabetic vs. normoglycemic conditions.Acta Biomater. 2022 Apr 15;143:310-319. doi: 10.1016/j.actbio.2022.03.007. Epub 2022 Mar 9. Acta Biomater. 2022. PMID: 35278688 Free PMC article.
-
Host-biomaterial interactions in mesh complications after pelvic floor reconstructive surgery.Nat Rev Urol. 2021 Dec;18(12):725-738. doi: 10.1038/s41585-021-00511-y. Epub 2021 Sep 20. Nat Rev Urol. 2021. PMID: 34545239 Review.
References
-
- Rogowski A, Bienkowski P, Tosiak A, Jerzak M, Mierzejewski P, Baranowski W. Mesh retraction correlates with vaginal pain and overactive bladder symptoms after anterior vaginal mesh repair. Int Urogynecol J. 2013 - PubMed
-
- Skala CE, Renezeder K, Albrich S, et al. Mesh complications following prolapse surgery: management and outcome. Eur J Obstet Gynecol Reprod Biol. 2011;159:453–456. - PubMed
-
- Baessler K, Hewson AD, Tunn R, Schuessler B, Maher CF. Severe mesh complications following intravaginal slingplasty. Obstet Gynecol. 2005;106:713–716. - PubMed
-
- Huebner M, Hsu Y, Fenner DE. The use of graft materials in vaginal pelvic floor surgery. Int J Gynaecol Obstet. 2006;92:279–288. - PubMed
-
- FDA Public Health Notification: Serious Complications Associated with Transvaginal Placement of Surgical Mesh in Repair of Pelvic Organ Prolapse and Stress Urinary Incontinence. [Accessed August 3, 2012];2011 at http://www.fda.gov/medicaldevices/safety/alertsandnotices/publichealthno....) - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
